JP3285452B2 - Toothpaste composition - Google Patents
Toothpaste compositionInfo
- Publication number
- JP3285452B2 JP3285452B2 JP21183594A JP21183594A JP3285452B2 JP 3285452 B2 JP3285452 B2 JP 3285452B2 JP 21183594 A JP21183594 A JP 21183594A JP 21183594 A JP21183594 A JP 21183594A JP 3285452 B2 JP3285452 B2 JP 3285452B2
- Authority
- JP
- Japan
- Prior art keywords
- hydroxyapatite
- dentifrice composition
- composition according
- vitamin
- fluoride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Cosmetics (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は歯磨組成物に関し、特に
う蝕予防に有効で、性状が経時的にも安定な歯磨組成物
に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a dentifrice composition, and more particularly to a dentifrice composition which is effective in preventing dental caries and has stable properties over time.
【0002】[0002]
【従来の技術および課題】ハイドロキシアパタイトは、
歯表面を傷つけることなく、う蝕の原因となる歯垢を除
去するとともに、歯の再石灰化を促進し歯を強化させる
こと(登録1553266、特開昭56-73014、登録1557631)、
また口腔内の口臭成分を吸着除去すること(特開平4-23
0315)など種々の効能を有していることが報告されてお
り、これを歯磨組成物に配合することは広く知られてい
る。2. Description of the Related Art Hydroxyapatite is
To remove dental plaque which causes dental caries without damaging the tooth surface, promote remineralization of teeth and strengthen teeth (registered 1553266, JP-A-56-73014, registered 1557631),
It is also necessary to absorb and remove bad breath components in the oral cavity (Japanese Patent Laid-Open No.
[0315] It has been reported that the compound has various effects, such as the use in dentifrice compositions.
【0003】ハイドロキシアパタイトは、他の化合物と
容易に反応し、例えば組成物中に可溶性フッ化物が同時
に存在すると、フッ素イオンが、歯のエナメル質のハイ
ドロキシアパタイトに作用する前に、組成物中のハイド
ロキシアパタイトと反応してフルオロアパタイトを形成
し、有効に働くフッ素化合物ではなくなってしまうこと
が知られている。このような問題を克服するため、例え
ば、特開平2-31049では、ハイドロキシアパタイト及び
フッ化物の少なくとも1つをマイクロカプセル化、或は
コーティングすることにより、それぞれが直接接触する
ことを避けている。また同様の考え方で、特公平6-8247
では、ハイドロキシアパタイトの表面に存在するヒドロ
キシ基を特定物質で前処理することにより、それぞれが
直接接触することを避け、可溶性フッ化物との反応を抑
制している。また、特開平3-193726では、ハイドロキシ
アパタイトと可溶性フッ化物を配合した口腔用組成物の
pHを7.0〜11.0にすることで有効フッ化物の損
失を減少させている。[0003] Hydroxyapatite reacts readily with other compounds, for example, if soluble fluoride is present in the composition at the same time, the fluoride ions are not allowed to act on the hydroxyapatite of the tooth enamel before they can act on the composition. It is known that it reacts with hydroxyapatite to form fluoroapatite, and is no longer a fluorine compound that works effectively. In order to overcome such a problem, for example, in Japanese Patent Application Laid-Open No. 2-31049, at least one of hydroxyapatite and fluoride is microencapsulated or coated to avoid direct contact with each other. In the same way, Japanese Patent Publication No. 6-8247
In this method, the hydroxy group present on the surface of hydroxyapatite is pretreated with a specific substance to avoid direct contact with each other and suppress the reaction with soluble fluoride. In JP-A-3-93726, the loss of effective fluoride is reduced by adjusting the pH of an oral composition containing hydroxyapatite and soluble fluoride to 7.0 to 11.0.
【0004】[0004]
【発明が解決しようとする課題】ところが、ハイドロキ
シアパタイトと可溶性フッ化物を配合した歯磨は、長期
間特に高温で放置した場合、また急激な温度変化がおこ
った場合、肌荒れが起こり、ひどい場合には固化がおこ
るため著しく使用感が損なわれるという問題があること
を知見した。この固化の問題については従来の技術で
は、何等ふれられておらず、たとえば特開平3-193726で
示される方法では解決できておらず、ハイドロキシアパ
タイトと可溶性フッ化物を配合した歯磨における経時で
の性状と外観の問題についての解決が必要であった。However, dentifrices containing hydroxyapatite and soluble fluoride, if left for a long period of time, especially at high temperatures, or if a rapid temperature change occurs, may cause rough skin, and in severe cases, It was found that there was a problem that the feeling of use was significantly impaired due to solidification. This problem of solidification has not been addressed in the prior art at all, and cannot be solved, for example, by the method disclosed in Japanese Patent Application Laid-Open No. 3-93726, and the properties over time in toothpastes containing a mixture of hydroxyapatite and soluble fluoride And a solution for the appearance problem was needed.
【0005】[0005]
【課題を解決するための手段】本発明者らは、このよう
な問題を解決すべく鋭意研究をおこなった結果、安定化
剤としてポリエチレングリコールおよびビタミンE誘導
体から選ばれる1種以上を含むことにより、ハイドロキ
シアパタイトと可溶性フッ化物が共に安定に配合され、
性状、外観ともに安定な歯磨組成物を得ることができ、
本発明を完成するに至った。Means for Solving the Problems The inventors of the present invention have made intensive studies to solve such problems, and as a result, by including at least one selected from polyethylene glycol and vitamin E derivatives as a stabilizer. , Both hydroxyapatite and soluble fluoride are stably compounded,
Properties, appearance can obtain a stable dentifrice composition,
The present invention has been completed.
【0006】本発明で用いられる安定化剤であるポリエ
チレングリコールとしては、重合度300〜600のも
のが適当であり、重合度300未満のものは、保水能が
充分でなく、重合度600をこえるものは、固体である
ため他の成分との相容性が悪くなる。また、その配合量
としては、1〜20%が好ましく、配合量が1%未満で
は性状、外観の安定化のためには不十分であリ、20%
をこえると使用感が悪くなる。さらに、ポリエチレング
リコールとハイドロキシアパタイトの重量比が1:0.
5〜1:50である場合、性状、外観の安定化に特に好
ましい。[0006] As the polyethylene glycol as a stabilizer used in the present invention, those having a degree of polymerization of 300 to 600 are suitable, and those having a degree of polymerization of less than 300 do not have sufficient water retention ability and exceed the degree of polymerization of 600. Since the solid is solid, it has poor compatibility with other components. The compounding amount is preferably 1 to 20%, and if the compounding amount is less than 1%, it is insufficient for stabilizing properties and appearance, and 20%
Beyond this, the usability will deteriorate. Further, the weight ratio of polyethylene glycol to hydroxyapatite is 1: 0.
A ratio of 5 to 1:50 is particularly preferred for stabilizing properties and appearance.
【0007】本発明で用いられる安定化剤であるビタミ
ンE誘導体としては、ニコチン酸トコフェロール、酢酸
トコフェロールであることが好ましく、特にニコチン酸
トコフェロールが好ましい。またその配合量は、0.0
1〜1%が好ましく、配合量が0.01%未満では、性
状、外観の安定化のためには不十分である。さらに、ビ
タミンE誘導体とハイドロキシアパタイトが重量比で
1:1〜1:1000である場合、性状、外観の安定化
に特に好ましい。[0007] The vitamin E derivative which is a stabilizer used in the present invention is preferably tocopherol nicotinate or tocopherol acetate, particularly preferably tocopherol nicotinate. The compounding amount is 0.0
The content is preferably 1 to 1%, and if the amount is less than 0.01%, it is insufficient for stabilizing properties and appearance. Further, when the weight ratio of the vitamin E derivative to hydroxyapatite is 1: 1 to 1: 1000, it is particularly preferable for stabilizing properties and appearance.
【0008】本発明で用いられる可溶性フッ化物として
は、モノフルオロリン酸ナトリウム、フッ化ナトリウ
ム、フッ化スズが好ましい。[0008] As the soluble fluoride used in the present invention, sodium monofluorophosphate, sodium fluoride and tin fluoride are preferable.
【0009】本発明で用いられるハイドロキシアパタイ
トとしては種々選択されるが、その中でも特に平均粒子
経が1〜50μm、より好ましくは3〜30μmのもの
が好ましい。平均粒子径が1μm未満では作業性が悪
く、50μmをこえたものでは使用感が損なわれる。ま
た、ハイドロキシアパタイトは通常1〜50%、より好
ましくは3〜10%配合することが望ましく、1%未満
であるとハイドロキシアパタイトの効果がみられず、5
0%をこえると良好な性状が得られにくい。さらに、本
発明で用いられるハイドロキシアパタイトの比表面積は
100m2 /g以下が好ましく、比表面積が100m2
/gをこえると、ハイドロキシアパタイトの反応性が高
くなり過ぎ、性状、外観の安定化に悪影響を及ぼす。The hydroxyapatite used in the present invention is variously selected, and among them, those having an average particle diameter of 1 to 50 μm, more preferably 3 to 30 μm are preferred. If the average particle diameter is less than 1 μm, the workability is poor, and if it exceeds 50 μm, the feeling of use is impaired. The content of hydroxyapatite is usually from 1 to 50%, more preferably from 3 to 10%. If it is less than 1%, the effect of hydroxyapatite is not observed, and
If it exceeds 0%, it is difficult to obtain good properties. Furthermore, the specific surface area of the hydroxyapatite used in the present invention is preferably 100 m 2 / g or less and a specific surface area of 100 m 2
If it exceeds / g, the reactivity of hydroxyapatite becomes too high, and adversely affects the stabilization of properties and appearance.
【0010】本発明の歯磨組成物は常法に従って練歯
磨、液状歯磨、錠剤のいずれの剤型にもすることがで
き、必要に応じて適宜な成分、例えば通常の口腔用組成
物に使用される研磨剤としては第二リン酸カルシウム、
第一リン酸カルシウム、第三リン酸カルシウム、炭酸カ
ルシウム、ピロリン酸カルシウム、水酸化アルミニウ
ム、アルミナ、無水ケイ酸、シリカゲル、ケイ酸アルミ
ニウム、不溶性メタリン酸ナトリウム、第三リン酸マグ
ネシウム、炭酸マグネシウム、硫酸カルシウム、ポリメ
タクリル酸メチル、ベントナイト、ケイ酸ジルコニウ
ム、合成樹脂等が使用され、湿潤剤としてはソルビッ
ト、プロピレングリコール、濃グリセリン、ポリエチレ
ングリコール等が使用され、増粘剤としてはカルボキシ
メチルセルロースナトリウム、カラギーナン、キサンタ
ンガム、アルギン酸ナトリウム、ヒドロキシエチルセル
ロース等が使用され、界面活性剤としてはラウリル硫酸
ナトリウム、ラウロイルサルコシンナトリウム、ショ糖
脂肪酸エステル、ラウリン酸ジエタノールアミド、ポリ
オキシエチレン硬化ヒマシ油、ポリオキシエチレン・ポ
リオキシプロピレンブロックコポリマー等が使用され、
その他安息香酸ナトリウム、メチルパラベン等の防腐
剤、、ペパーミント、スペアミント等の精油、l−メン
トール、カルボン、アネトール等の香料素材等の香料、
サッカリンナトリウム、ステビオサイド、ネオヘスペリ
ジルジヒドロカルコン、グリチルリチン、ソーマチン、
ペリラルチン、P−メトキシシンナミックアルデヒド、
キシリトール等の甘味剤、および塩化セチルピリジニウ
ム、塩酸クロルヘキシジン、トリクロサン、デキストラ
ナーゼ、ムタナーゼ、ヒノキチオール、リゾチーム、ア
ラントイン、グリチルリチン酸ジカリウム、イプシロン
アミノカプロン酸、トラネキサム酸、塩化ナトリウム、
アズレン、イソプロピルメチルフェノール等の有効成分
を本発明の効果を損なわない範囲で配合することができ
る。The dentifrice composition of the present invention can be made into any form of toothpaste, liquid dentifrice or tablet according to a conventional method, and may be used as appropriate, if necessary, for example, an ordinary oral composition. Dibasic calcium phosphate,
Monobasic calcium phosphate, tribasic calcium phosphate, calcium carbonate, calcium pyrophosphate, aluminum hydroxide, alumina, silicic anhydride, silica gel, aluminum silicate, insoluble sodium metaphosphate, tribasic magnesium phosphate, magnesium carbonate, calcium sulfate, polymethacrylic acid Methyl, bentonite, zirconium silicate, synthetic resin, etc. are used.Sorbit, propylene glycol, concentrated glycerin, polyethylene glycol, etc. are used as wetting agents, and carboxymethylcellulose sodium, carrageenan, xanthan gum, sodium alginate are used as thickeners. Hydroxyethyl cellulose and the like are used, and as a surfactant, sodium lauryl sulfate, sodium lauroyl sarcosine, sucrose fatty acid ester, lauri Acid diethanolamide, polyoxyethylene hardened castor oil, polyoxyethylene-polyoxypropylene block copolymer or the like is used,
Other preservatives such as sodium benzoate and methyl paraben; essential oils such as peppermint and spearmint; fragrances such as fragrance materials such as l-menthol, carvone and anethole;
Saccharin sodium, stevioside, neohesperidyl dihydrochalcone, glycyrrhizin, thaumatin,
Perillartin, P-methoxycinnamic aldehyde,
Sweeteners such as xylitol, and cetylpyridinium chloride, chlorhexidine hydrochloride, triclosan, dextranase, mutanase, hinokitiol, lysozyme, allantoin, dipotassium glycyrrhizinate, epsilon aminocaproic acid, tranexamic acid, sodium chloride,
Active ingredients such as azulene and isopropylmethylphenol can be blended within a range that does not impair the effects of the present invention.
【0011】[0011]
【実施例】以下、実施例と実験例により本発明をさらに
詳しく説明する。 実施例1〜15および比較例1 実験 表1にしめす練歯磨きを定法に従って製造し、各歯磨に
ついて55℃で3ヶ月放置後、性状と使用感について次
の評価基準で評価した。 (評価基準) ○:良好 △:やや問題あり ×:問題あり (総合評価) ◎:性状、使用感ともに○である ○:性状、使用感いずれかに△がある ×:性状、使用感いずれかが× であるThe present invention will be described below in more detail with reference to Examples and Experimental Examples. Examples 1 to 15 and Comparative Example 1 Experiment Toothpastes shown in Table 1 were manufactured according to a standard method, and after each toothpaste was left at 55 ° C for 3 months, properties and feeling of use were evaluated according to the following evaluation criteria. (Evaluation criteria) ○: Good △: Somewhat problematic X: Problematic (Comprehensive evaluation) ◎: Both properties and feeling of use are ○ ○: Either property or feeling of use ×: Any of properties and feeling of use Is ×
【表1】 表1に示す結果より明らかなように、特定重合度のポリ
エチレングリコールとビタミンE誘導体から選ばれる一
種または二種以上を含むことにより、性状、外観ともに
安定であることがわかる。[Table 1] As is clear from the results shown in Table 1, it can be seen that by containing one or more selected from polyethylene glycol having a specific polymerization degree and a vitamin E derivative, both properties and appearance are stable.
【0012】 [0012]
【0013】 [0013]
【0014】 [0014]
【0015】[0015]
【発明の効果】本発明によれば、う蝕予防に有効で、性
状が経時的にも安定な歯磨組成物が得られる。According to the present invention, a dentifrice composition which is effective in preventing dental caries and whose properties are stable over time can be obtained.
Claims (7)
物を配合した歯磨組成物において、安定化剤としてポリ
エチレングリコールおよびビタミンE誘導体を含むこと
を特徴とする歯磨組成物。1. A dentifrice composition containing hydroxyapatite and a soluble fluoride, comprising polyethylene glycol and a vitamin E derivative as stabilizers.
1〜50μmであって、比表面積が100m2/g以下
である請求項1記載の歯磨組成物。2. The dentifrice composition according to claim 1, wherein the average particle size of the hydroxyapatite is 1 to 50 μm and the specific surface area is 100 m 2 / g or less.
イトが重量比で1:1〜1:1000である請求項1記
載の歯磨組成物。3. The dentifrice composition according to claim 1, wherein the weight ratio of the vitamin E derivative to hydroxyapatite is 1: 1 to 1: 1000.
トリウム、フッ化ナトリウム、フッ化スズの一種または
二種以上である請求項1記載の歯磨組成物。4. The dentifrice composition according to claim 1, wherein the soluble fluoride is one or more of sodium monofluorophosphate, sodium fluoride and tin fluoride.
ロール、酢酸トコフェロールから選ばれる1種以上であ
る請求項1記載の歯磨組成物。5. The dentifrice composition according to claim 1, wherein the vitamin E derivative is at least one selected from tocopherol nicotinate and tocopherol acetate.
ロールである請求項1記載の歯磨組成物。6. The dentifrice composition according to claim 1, wherein the vitamin E derivative is tocopherol nicotinate.
ェロールの配合量が0.01〜1%である請求項1記載
の歯磨組成物。7. The dentifrice composition according to claim 1, wherein the compounding amount of tocopherol nicotinate and tocopherol acetate is 0.01 to 1%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21183594A JP3285452B2 (en) | 1994-08-11 | 1994-08-11 | Toothpaste composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21183594A JP3285452B2 (en) | 1994-08-11 | 1994-08-11 | Toothpaste composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0853331A JPH0853331A (en) | 1996-02-27 |
JP3285452B2 true JP3285452B2 (en) | 2002-05-27 |
Family
ID=16612382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP21183594A Expired - Fee Related JP3285452B2 (en) | 1994-08-11 | 1994-08-11 | Toothpaste composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3285452B2 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE10336400A1 (en) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Anti-abuse dosage form |
DE10361596A1 (en) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Process for producing an anti-abuse dosage form |
DE102005005446A1 (en) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Break-resistant dosage forms with sustained release |
DE102005005449A1 (en) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Process for producing an anti-abuse dosage form |
NZ586792A (en) | 2008-01-25 | 2012-09-28 | Gruenenthal Chemie | Tamper resistant controlled release pharmaceutical tablets form having convex and concave surfaces |
RU2508092C2 (en) * | 2008-05-09 | 2014-02-27 | Грюненталь Гмбх | Method for preparing solid dosage form, particularly tablet for pharmaceutical application and method for preparing solid dosage form precursor, particularly tablet |
CN102573805A (en) | 2009-07-22 | 2012-07-11 | 格吕伦塔尔有限公司 | Hot-melt extruded controlled release dosage form |
WO2011009604A1 (en) | 2009-07-22 | 2011-01-27 | Grünenthal GmbH | Oxidation-stabilized tamper-resistant dosage form |
PL2611426T3 (en) | 2010-09-02 | 2014-09-30 | Gruenenthal Gmbh | Tamper resistant dosage form comprising inorganic salt |
RU2607499C2 (en) | 2010-09-02 | 2017-01-10 | Грюненталь Гмбх | Destruction-resistant dosage form containing anionic polymer |
BR112014002022A2 (en) | 2011-07-29 | 2017-02-21 | Gruenenthal Gmbh | tamper-resistant tablet providing immediate drug release |
PT2736497T (en) | 2011-07-29 | 2017-11-30 | Gruenenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
EP2819656A1 (en) | 2012-02-28 | 2015-01-07 | Grünenthal GmbH | Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
MX362357B (en) | 2012-04-18 | 2019-01-14 | Gruenenthal Gmbh | Tamper resistant and dose-dumping resistant pharmaceutical dosage form. |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
EP3003283A1 (en) | 2013-05-29 | 2016-04-13 | Grünenthal GmbH | Tamper resistant dosage form with bimodal release profile |
US10154966B2 (en) | 2013-05-29 | 2018-12-18 | Grünenthal GmbH | Tamper-resistant dosage form containing one or more particles |
WO2015004245A1 (en) | 2013-07-12 | 2015-01-15 | Grünenthal GmbH | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
CN105934241B (en) | 2013-11-26 | 2020-06-05 | 格吕伦塔尔有限公司 | Preparation of powdered pharmaceutical composition by cryogenic grinding |
EP3142646A1 (en) | 2014-05-12 | 2017-03-22 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
EP3148512A1 (en) | 2014-05-26 | 2017-04-05 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
MX2017013637A (en) | 2015-04-24 | 2018-03-08 | Gruenenthal Gmbh | Tamper-resistant dosage form with immediate release and resistance against solvent extraction. |
US10842750B2 (en) | 2015-09-10 | 2020-11-24 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
-
1994
- 1994-08-11 JP JP21183594A patent/JP3285452B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH0853331A (en) | 1996-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3285452B2 (en) | Toothpaste composition | |
JPS6234013B2 (en) | ||
DE69535286T2 (en) | Oral formulation for improved bleaching of teeth | |
JPH1121219A (en) | Composition for oral cavity | |
JPH0725658B2 (en) | Oral composition | |
JPS6217966B2 (en) | ||
JPH1087458A (en) | Composition for oral cavity | |
JP2586896B2 (en) | Oral composition | |
JP2000256153A (en) | Oral composition | |
JPH1171251A (en) | Composition for oral cavity | |
JP3189549B2 (en) | Oral composition | |
JP4539796B2 (en) | Dentifrice composition | |
JP4257001B2 (en) | Oral composition | |
JP4496420B2 (en) | Dentifrice composition | |
JP3503425B2 (en) | Toothpaste composition | |
JP2001163743A (en) | Dentifrice composition | |
JPH11130648A (en) | Composition for oral cavity | |
JP2806029B2 (en) | Oral composition | |
JP2000063251A (en) | Composition for oral cavity | |
JPH11286422A (en) | Composition for oral cavity application | |
JP3482323B2 (en) | Oral composition | |
JP2806024B2 (en) | Oral composition | |
JPS6216925B2 (en) | ||
JPH0772125B2 (en) | Oral composition | |
JP2000319153A (en) | Composition for oral cavity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20020219 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080308 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090308 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100308 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110308 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120308 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120308 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130308 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130308 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140308 Year of fee payment: 12 |
|
LAPS | Cancellation because of no payment of annual fees |